Co-Authors
This is a "connection" page, showing publications co-authored by AKHILA S REDDY and ALI HAIDER.
Connection Strength
2.797
-
Levorphanol versus methadone use: safety considerations. Ann Palliat Med. 2020 Mar; 9(2):579-585.
Score: 0.712
-
Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids. J Pain Symptom Manage. 2024 Dec; 68(6):e500-e507.
Score: 0.243
-
Impact of an Institution-Wide Goals of Care Program on the Timing of Referrals to Outpatient Palliative Care. J Pain Symptom Manage. 2023 12; 66(6):e666-e671.
Score: 0.227
-
Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. J Pain Symptom Manage. 2023 06; 65(6):e683-e690.
Score: 0.218
-
Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. J Palliat Med. 2022 Oct; 25(10):1557-1562.
Score: 0.211
-
Oncology patients' perception of physicians who use an integrated electronic health record (EHR) during clinic visits: PRIME-EHR double-blind, randomized controlled trial. Cancer. 2021 11 01; 127(21):3967-3974.
Score: 0.196
-
A retrospective review of the use of oxymorphone immediate release for long term pain control in cancer patients with gastrostomy tubes. Ann Palliat Med. 2021 Mar; 10(3):2662-2667.
Score: 0.190
-
Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic. Cancer. 2019 Dec 15; 125(24):4525-4531.
Score: 0.172
-
Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. JAMA Oncol. 2019 Jun 01; 5(6):841-846.
Score: 0.169
-
The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients. Cancer. 2016 Jan 01; 122(1):149-56.
Score: 0.131
-
Coping Strategies and Associated Symptom Burden Among Patients With Advanced Cancer. Oncologist. 2024 Feb 02; 29(2):166-175.
Score: 0.058
-
Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer. 2021 03 15; 127(6):968-975.
Score: 0.047
-
Management challenges at end-of-life in a patient with agitated delirium and benzodiazepine withdrawal at comprehensive cancer care center. Ann Palliat Med. 2021 Jun; 10(6):6979-6983.
Score: 0.047
-
Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol. 2020 07; 21(7):989-998.
Score: 0.045
-
Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers (Basel). 2020 Jan 15; 12(1).
Score: 0.044
-
Practices and perceptions regarding intravenous opioid infusion and cancer pain management. Cancer. 2019 11 01; 125(21):3882-3889.
Score: 0.043
-
Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage. 2019 10; 58(4):605-613.
Score: 0.043